Objective Amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG) are caused,
respectively, by motor neuron degeneration and neuromuscular junction (NMJ) dysfunction …

Myasthenia gravis (MG) is an autoimmune disorder characterized by a defect in synaptic
transmission at the neuromuscular junction causing fluctuating muscle weakness with a …

Background Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients
have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while …

Introduction We assessed antibodies against low‐density lipoprotein receptor‐related
protein 4 (LRP4‐Ab) in a Chinese population with myasthenia gravis (MG). Methods Serum …

Objectives To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …

Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK
antibodies) presents a serious gap in MG diagnosis and understanding. Recently …

Background LRP4 is a post-synaptic membrane protein that promotes acetylcholine (AChR)
clustering on the crest of post-synaptic neuromuscular folds. Autoantibodies against LRP4 …

Background and purpose Low‐density‐lipoprotein‐receptor‐associated protein 4 (LRP4)
autoantibodies have recently been detected in myasthenia gravis (MG), but little is known …

Since the first report of experimental animal models of myasthenia gravis (MG) with
autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), there have …

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, where
acetylcholine receptor (AChR), muscle‐specific kinase (MuSK), and low‐density lipoprotein …